This hyperlipidemia is thought to be mediated via downregulation of PPAR-γ and subsequently affect GLUT4 and FAT/CD36 expression resulting in glucose and fatty acid transporters expression and causing hyperglycemia and hyperlipidemia [65]. This evidence concerns the gene SLC2A4 and hyperlipidemia.